Status:
COMPLETED
High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China
Lead Sponsor:
The George Institute for Global Health, China
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Cardiovascular disease is the leading cause of death in China. At the village level, strategies for the control of cardiovascular disease are mostly absent. National clinical guidelines for the manage...
Eligibility Criteria
Inclusion
- Physician-diagnosed history of coronary heart disease, ischemic stroke, or hemorrhagic stroke, or
- Older age (50 years or older for men; 60 years or older for women) and having physician-diagnosed Type I or Type II diabetes
- Older age (50 years or older for men; 60 years or older for women) and systolic blood pressure 160 mmHg (note that for simplicity, diastolic blood pressure is not included in the criteria)
Exclusion
- none
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01259700
Start Date
December 1 2010
End Date
June 1 2014
Last Update
February 17 2016
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebei Province Center for Disease Prevention and Control ,China
Shijiazhuang, Hebei, China
2
The First Hospital Of China Medical University
Shenyang, Liaoning, China
3
Ningxia Medical University School of Public Health
Yinchuan, Ningxia, China
4
Changzhi Medical College, China
Changzhi, Shanxi, China